Your browser doesn't support javascript.
loading
The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism.
Hommel, Adrianus L A J; Meinders, Marjan J; Lorenzl, Stefan; Dodel, Richard; Coelho, Miguel; Ferreira, Joaquim J; Laurens, Brice; Spampinato, Umberto; Meissner, Wassilios; Rosqvist, Kristina; Timpka, Jonathan; Odin, Per; Wittenberg, Michael; Bloem PhD, Bas R; Koopmans, Raymond T; Schrag, Anette.
Afiliación
  • Hommel ALAJ; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour Department of Neurology, Centre of Expertise for Parkinson & Movement Disorders Nijmegen the Netherlands.
  • Meinders MJ; Groenhuysen Organisation Roosendaal the Netherlands.
  • Lorenzl S; Radboud University Medical Center Radboud Institute for Health Sciences Nijmegen the Netherlands.
  • Dodel R; Interdisziplinäres Zentrum für Palliativmedizin und Klinik für Neurologie Universität München-Klinikum Großhadern Munich Germany.
  • Coelho M; Institute of Nursing Science and Practice Salzburg Austria.
  • Ferreira JJ; Department of Geriatric Medicine University Hospital Essen Essen Germany.
  • Laurens B; University of Lisbon, Lisbon School of Medicine (FMUL), Laboratory of Clinical Pharmacology and Therapeutics, Lisbon, Portugal; and University of Lisbon Lisbon School of Medicine (FMUL), Instituto de Medicina Molecular Lisbon Portugal.
  • Spampinato U; University of Lisbon Lisbon School of Medicine (FMUL), Instituto de Medicina Molecular Lisbon Portugal.
  • Meissner W; Department of Neurosciences Service of Neurology, Hospital Santa Maria Lisbon Portugal.
  • Rosqvist K; University of Lisbon, Lisbon School of Medicine (FMUL), Laboratory of Clinical Pharmacology and Therapeutics, Lisbon, Portugal; and University of Lisbon Lisbon School of Medicine (FMUL), Instituto de Medicina Molecular Lisbon Portugal.
  • Timpka J; Service de Neurologie CHU de Bordeaux 33000 Bordeaux France.
  • Odin P; Univ. de Bordeaux, Institut des Maladies Neurodégénératives Bordeaux France.
  • Wittenberg M; Service de Neurologie CHU de Bordeaux 33000 Bordeaux France.
  • Bloem PhD BR; Univ. de Bordeaux, Institut des Maladies Neurodégénératives Bordeaux France.
  • Koopmans RT; Service de Neurologie CHU de Bordeaux 33000 Bordeaux France.
  • Schrag A; Univ. de Bordeaux, Institut des Maladies Neurodégénératives Bordeaux France.
Mov Disord Clin Pract ; 7(5): 531-542, 2020 Jul.
Article en En | MEDLINE | ID: mdl-32626798
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mov Disord Clin Pract Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mov Disord Clin Pract Año: 2020 Tipo del documento: Article